| Literature DB >> 28445593 |
Abstract
Pancreatic cancers depend on driver molecules, oncogene proteins such as RAS. NR5A2 protein is a transcription factor and either activates or inhibits transcription through actions at hundreds of enhancers. It has unusual properties with effects appearing in multiple signaling networks. NR5A2 is a pluripotency reprogramming factor in the class nuclear receptor. Its controlling hormone is PIP3. Experiments suggest NR5A2 activation drives PDAC and inhibitors blunt cancer cell proliferation.Entities:
Keywords: LRH-1; stem cell; structure-based inhibitor design; β-catenin
Mesh:
Substances:
Year: 2017 PMID: 28445593 PMCID: PMC5519325 DOI: 10.1002/jso.24639
Source DB: PubMed Journal: J Surg Oncol ISSN: 0022-4790 Impact factor: 3.454